0000899243-22-013322.txt : 20220404
0000899243-22-013322.hdr.sgml : 20220404
20220404161531
ACCESSION NUMBER: 0000899243-22-013322
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doebele Robert
CENTRAL INDEX KEY: 0001856681
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40356
FILM NUMBER: 22802369
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rain Therapeutics Inc.
CENTRAL INDEX KEY: 0001724979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821130967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: (510) 953-5559
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-31
0
0001724979
Rain Therapeutics Inc.
RAIN
0001856681
Doebele Robert
C/O RAIN THERAPEUTICS INC.
8000 JARVIS AVENUE, SUITE 204
NEWARK
CA
94560
0
1
0
0
See Remarks
Common Stock
2022-03-31
4
M
0
2000
3.95
A
469937
D
Stock Option (Right to Buy)
3.95
2022-03-31
4
M
0
2000
0.00
D
2029-03-13
Common Stock
2000
11890
D
This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full.
President, Chief Scientific Officer
/s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele
2022-04-04